Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

نتائج البحث

Display Settings
النتائج لكل صفحة: 10
Sort By: Relevance
Filter
  • 1-10 ل  196,167 نتائج ل ""Combined""

فلترة النتائج

Content Provider : MEDLINE
إعادة تعيين خيارات الفبترة
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

A Single-Arm Phase II Clinical Trial of Fulvestrant Combined with Neoadjuvant Chemotherapy of ER+/HER2- Locally Advanced Breast Cancer: Integrated Analysis of 18F-FES PET-CT and Metabolites with Treatment Response.

  • Authors : Shao Q; Department of Breast Cancer Center, Chongqing University Cancer Hospital, Chongqing, China.; Zhang N

Subjects: Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/drug therapy ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/metabolism ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/pathology

  • Source: Cancer research and treatment [Cancer Res Treat] 2025 Jan; Vol. 57 (1), pp. 126-139. Date of Electronic Publication: 2024 Jul 09.Publisher: Korean Cancer Association Country of Publication: Korea (South) NLM ID: 101155137 Publication Model: Print-Electronic Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Report

Persistent response to combination therapy of pemigatinib and chemotherapy in a child of combined hepatocellular-cholangiocarcinoma with FGFR2 fusion.

  • Authors : He GQ; Key Laboratory of Birth Defects and Related Diseases of Women and Children, West China Second University Hospital, Ministry of Education, Sichuan University, Chengdu, 610041, Sichuan, P.R. China.; Department of Pediatrics,West China Second University Hospital, Sichuan University, Section 3, South Renmin Road, Chengdu, 610041, Sichuan, P.R. China.

Subjects: Receptor, Fibroblast Growth Factor, Type 2*/Receptor, Fibroblast Growth Factor, Type 2*/Receptor, Fibroblast Growth Factor, Type 2*/genetics ; Receptor, Fibroblast Growth Factor, Type 2*/Receptor, Fibroblast Growth Factor, Type 2*/Receptor, Fibroblast Growth Factor, Type 2*/metabolism ; Receptor, Fibroblast Growth Factor, Type 2*/Receptor, Fibroblast Growth Factor, Type 2*/Receptor, Fibroblast Growth Factor, Type 2*/antagonists & inhibitors

  • Source: Molecular cancer [Mol Cancer] 2024 Dec 06; Vol. 23 (1), pp. 269. Date of Electronic Publication: 2024 Dec 06.Publisher: BioMed Central Country of Publication: England NLM ID: 101147698 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-4598

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

The Efficacy and Safety of Albumin-Bound Paclitaxel Combined With Anlotinib and PD-1/L1 Inhibitors For Treating Patients With Extensive-Stage Small Cell Lung Cancer and Brain Metastasis: A Retrospective Cohort Study.

  • Authors : Li X; Department of Thoracic Oncology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.; Wu

Subjects: Indoles*/Indoles*/Indoles*/therapeutic use ; Indoles*/Indoles*/Indoles*/administration & dosage ; Indoles*/Indoles*/Indoles*/adverse effects

  • Source: Cancer medicine [Cancer Med] 2024 Dec; Vol. 13 (23), pp. e70449.Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

The efficacy and safety of a taxane-based chemotherapy regimen combined with a PD-1 inhibitor in HNSCC: a multicenter real-world study.

  • Authors : Ouyang M; Department of Gerontology, The Second Xiangya Hospital of Central South University, Changsha, China.; Sun H

Subjects: Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/therapeutic use ; Taxoids*/Taxoids*/Taxoids*/administration & dosage ; Squamous Cell Carcinoma of Head and Neck*/Squamous Cell Carcinoma of Head and Neck*/Squamous Cell Carcinoma of Head and Neck*/drug therapy

  • Source: World journal of surgical oncology [World J Surg Oncol] 2025 Jan 04; Vol. 23 (1), pp. 6. Date of Electronic Publication: 2025 Jan 04.Publisher: BioMed Central Country of Publication: England NLM ID: 101170544 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-7819

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

First-line endocrine therapy combined with CDK 4/6 inhibitor in disseminated carcinomatosis of bone marrow (DCBM) luminal breast cancer: a case report.

  • Authors : Pangarsa EA; Hematology Medical Oncology Division, Faculty of Medicine, Diponegoro University/Dr. Kariadi General Hospital Semarang, Semarang, Indonesia.; Elisabeth Hospital Semarang, Semarang, Indonesia.

Subjects: Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/drug therapy ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/pathology ; Cyclin-Dependent Kinase 4*/Cyclin-Dependent Kinase 4*/Cyclin-Dependent Kinase 4*/antagonists & inhibitors

  • Source: Journal of medical case reports [J Med Case Rep] 2024 Dec 05; Vol. 18 (1), pp. 591. Date of Electronic Publication: 2024 Dec 05.Publisher: BioMed Central Country of Publication: England NLM ID: 101293382 Publication Model: Electronic Cited Medium: Internet ISSN: 1752-1947

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Rapid Response to Penpulimab Combined With Anlotinib and Chemotherapy in a Thoracic SMARCA4-UT Without PD-L1 Expression: A Case Report and Review of Literature.

  • Authors : Wang Y; Department of Oncology, The First Affiliated Hospital of Xinxiang Medical University, Weihui, China.; Zhao K

Subjects: Quinolines*/Quinolines*/Quinolines*/therapeutic use ; Quinolines*/Quinolines*/Quinolines*/administration & dosage ; Indoles*/Indoles*/Indoles*/therapeutic use

  • Source: The clinical respiratory journal [Clin Respir J] 2024 Dec; Vol. 18 (12), pp. e70036.Publisher: Blackwell Publishing Country of Publication: England NLM ID: 101315570 Publication Model: Print Cited Medium: Internet ISSN: 1752-699X

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

The efficacy and safety of Radiofrequency ablation combined with Lenvatinib plus Sintilimab in Unresectable Hepatocellular Carcinoma: a real-world study.

  • Authors : Wang X; Institute of Hepatobiliary Surgery, Southwest Hospital, Army Medical University, Chongqing, 400038, China.; Sun X

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/drug therapy ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/therapy ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/mortality

  • Source: BMC cancer [BMC Cancer] 2024 Aug 22; Vol. 24 (1), pp. 1036. Date of Electronic Publication: 2024 Aug 22.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Clinical efficacy and safety of irreversible electroporation combined with chemotherapy in stage IV pancreatic cancer treatment.

  • Authors : Zeng J; Department of Radiology, Tianjin Medical University General Hospital, Tianjin, China.; Liu B

Subjects: Pancreatic Neoplasms*/Pancreatic Neoplasms*/Pancreatic Neoplasms*/drug therapy ; Pancreatic Neoplasms*/Pancreatic Neoplasms*/Pancreatic Neoplasms*/therapy ; Pancreatic Neoplasms*/Pancreatic Neoplasms*/Pancreatic Neoplasms*/pathology

  • Source: Journal of cancer research and therapeutics [J Cancer Res Ther] 2024 Aug 01; Vol. 20 (4), pp. 1357-1361. Date of Electronic Publication: 2024 Aug 29.Publisher: Medknow Publications Country of Publication: India NLM ID: 101249598 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Development of breakthrough bleeding model of combined-oral contraceptives utilizing model-based meta-analysis.

  • Authors : Chen H; Department of Pharmaceutics, College of Pharmacy, Center for Pharmacometrics and Systems Pharmacology, University of Florida, Orlando, Florida, USA.; Chun D

Subjects: Contraceptives, Oral, Combined*/Contraceptives, Oral, Combined*/Contraceptives, Oral, Combined*/administration & dosage ; Contraceptives, Oral, Combined*/Contraceptives, Oral, Combined*/Contraceptives, Oral, Combined*/adverse effects ; Ethinyl Estradiol*/Ethinyl Estradiol*/Ethinyl Estradiol*/administration & dosage

  • Source: CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2024 Nov; Vol. 13 (11), pp. 2016-2025. Date of Electronic Publication: 2024 Nov 17.Publisher: Wiley Country of Publication: United States NLM ID: 101580011 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

A randomized phase II trial on the addition of dutasteride to combined androgen blockade therapy versus combined androgen blockade therapy alone in patients with advanced or metastatic salivary duct carcinoma - the DUCT study protocol.

  • Authors : Weijers JAM; Department of Medical Oncology, Radboud Institute for Medical Innovation, Radboud University Medical Center, Geert Grooteplein Zuid 8, Nijmegen, 6525 GA, The Netherlands.; Verhaegh GW

Subjects: Androgen Antagonists*/Androgen Antagonists*/Androgen Antagonists*/therapeutic use ; Androgen Antagonists*/Androgen Antagonists*/Androgen Antagonists*/administration & dosage ; Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/therapeutic use

  • Source: BMC cancer [BMC Cancer] 2024 Sep 20; Vol. 24 (1), pp. 1174. Date of Electronic Publication: 2024 Sep 20.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
  • 1-10 ل  196,167 نتائج ل ""Combined""